Cargando…

Managing and treating per- and polyfluoroalkyl substances (PFAS) in membrane concentrates

Per- and polyfluoroalkyl substances (PFAS), which are present in many waters, have detrimental impacts on human health and the environment. Reverse osmosis (RO) and nanofiltration (NF) have shown excellent PFAS separation performance in water treatment; however, these membrane systems do not destroy...

Descripción completa

Detalles Bibliográficos
Autores principales: Tow, Emily W., Ersan, Mahmut Selim, Kum, Soyoon, Lee, Tae, Speth, Thomas F., Owen, Christine, Bellona, Christopher, Nadagouda, Mallikarjuna N., Mikelonis, Anne M., Westerhoff, Paul, Mysore, Chandra, Frenkel, Val S., deSilva, Viraj, Walker, W. Shane, Safulko, Andrew K., Ladner, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687045/
https://www.ncbi.nlm.nih.gov/pubmed/34938982
http://dx.doi.org/10.1002/aws2.1233
_version_ 1784618136567283712
author Tow, Emily W.
Ersan, Mahmut Selim
Kum, Soyoon
Lee, Tae
Speth, Thomas F.
Owen, Christine
Bellona, Christopher
Nadagouda, Mallikarjuna N.
Mikelonis, Anne M.
Westerhoff, Paul
Mysore, Chandra
Frenkel, Val S.
deSilva, Viraj
Walker, W. Shane
Safulko, Andrew K.
Ladner, David A.
author_facet Tow, Emily W.
Ersan, Mahmut Selim
Kum, Soyoon
Lee, Tae
Speth, Thomas F.
Owen, Christine
Bellona, Christopher
Nadagouda, Mallikarjuna N.
Mikelonis, Anne M.
Westerhoff, Paul
Mysore, Chandra
Frenkel, Val S.
deSilva, Viraj
Walker, W. Shane
Safulko, Andrew K.
Ladner, David A.
author_sort Tow, Emily W.
collection PubMed
description Per- and polyfluoroalkyl substances (PFAS), which are present in many waters, have detrimental impacts on human health and the environment. Reverse osmosis (RO) and nanofiltration (NF) have shown excellent PFAS separation performance in water treatment; however, these membrane systems do not destroy PFAS but produce concentrated residual streams that need to be managed. Complete destruction of PFAS in RO and NF concentrate streams is ideal, but long-term sequestration strategies are also employed. Because no single technology is adequate for all situations, a range of processes are reviewed here that hold promise as components of treatment schemes for PFAS-laden membrane system concentrates. Attention is also given to relevant concentration processes because it is beneficial to reduce concentrate volume prior to PFAS destruction or sequestration. Given the costs and challenges of managing PFAS in membrane concentrates, it is critical to evaluate both established and emerging technologies in selecting processes for immediate use and continued research.
format Online
Article
Text
id pubmed-8687045
institution National Center for Biotechnology Information
language English
publishDate 2021
record_format MEDLINE/PubMed
spelling pubmed-86870452022-09-02 Managing and treating per- and polyfluoroalkyl substances (PFAS) in membrane concentrates Tow, Emily W. Ersan, Mahmut Selim Kum, Soyoon Lee, Tae Speth, Thomas F. Owen, Christine Bellona, Christopher Nadagouda, Mallikarjuna N. Mikelonis, Anne M. Westerhoff, Paul Mysore, Chandra Frenkel, Val S. deSilva, Viraj Walker, W. Shane Safulko, Andrew K. Ladner, David A. AWWA Water Sci Article Per- and polyfluoroalkyl substances (PFAS), which are present in many waters, have detrimental impacts on human health and the environment. Reverse osmosis (RO) and nanofiltration (NF) have shown excellent PFAS separation performance in water treatment; however, these membrane systems do not destroy PFAS but produce concentrated residual streams that need to be managed. Complete destruction of PFAS in RO and NF concentrate streams is ideal, but long-term sequestration strategies are also employed. Because no single technology is adequate for all situations, a range of processes are reviewed here that hold promise as components of treatment schemes for PFAS-laden membrane system concentrates. Attention is also given to relevant concentration processes because it is beneficial to reduce concentrate volume prior to PFAS destruction or sequestration. Given the costs and challenges of managing PFAS in membrane concentrates, it is critical to evaluate both established and emerging technologies in selecting processes for immediate use and continued research. 2021-09-02 /pmc/articles/PMC8687045/ /pubmed/34938982 http://dx.doi.org/10.1002/aws2.1233 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ).
spellingShingle Article
Tow, Emily W.
Ersan, Mahmut Selim
Kum, Soyoon
Lee, Tae
Speth, Thomas F.
Owen, Christine
Bellona, Christopher
Nadagouda, Mallikarjuna N.
Mikelonis, Anne M.
Westerhoff, Paul
Mysore, Chandra
Frenkel, Val S.
deSilva, Viraj
Walker, W. Shane
Safulko, Andrew K.
Ladner, David A.
Managing and treating per- and polyfluoroalkyl substances (PFAS) in membrane concentrates
title Managing and treating per- and polyfluoroalkyl substances (PFAS) in membrane concentrates
title_full Managing and treating per- and polyfluoroalkyl substances (PFAS) in membrane concentrates
title_fullStr Managing and treating per- and polyfluoroalkyl substances (PFAS) in membrane concentrates
title_full_unstemmed Managing and treating per- and polyfluoroalkyl substances (PFAS) in membrane concentrates
title_short Managing and treating per- and polyfluoroalkyl substances (PFAS) in membrane concentrates
title_sort managing and treating per- and polyfluoroalkyl substances (pfas) in membrane concentrates
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687045/
https://www.ncbi.nlm.nih.gov/pubmed/34938982
http://dx.doi.org/10.1002/aws2.1233
work_keys_str_mv AT towemilyw managingandtreatingperandpolyfluoroalkylsubstancespfasinmembraneconcentrates
AT ersanmahmutselim managingandtreatingperandpolyfluoroalkylsubstancespfasinmembraneconcentrates
AT kumsoyoon managingandtreatingperandpolyfluoroalkylsubstancespfasinmembraneconcentrates
AT leetae managingandtreatingperandpolyfluoroalkylsubstancespfasinmembraneconcentrates
AT speththomasf managingandtreatingperandpolyfluoroalkylsubstancespfasinmembraneconcentrates
AT owenchristine managingandtreatingperandpolyfluoroalkylsubstancespfasinmembraneconcentrates
AT bellonachristopher managingandtreatingperandpolyfluoroalkylsubstancespfasinmembraneconcentrates
AT nadagoudamallikarjunan managingandtreatingperandpolyfluoroalkylsubstancespfasinmembraneconcentrates
AT mikelonisannem managingandtreatingperandpolyfluoroalkylsubstancespfasinmembraneconcentrates
AT westerhoffpaul managingandtreatingperandpolyfluoroalkylsubstancespfasinmembraneconcentrates
AT mysorechandra managingandtreatingperandpolyfluoroalkylsubstancespfasinmembraneconcentrates
AT frenkelvals managingandtreatingperandpolyfluoroalkylsubstancespfasinmembraneconcentrates
AT desilvaviraj managingandtreatingperandpolyfluoroalkylsubstancespfasinmembraneconcentrates
AT walkerwshane managingandtreatingperandpolyfluoroalkylsubstancespfasinmembraneconcentrates
AT safulkoandrewk managingandtreatingperandpolyfluoroalkylsubstancespfasinmembraneconcentrates
AT ladnerdavida managingandtreatingperandpolyfluoroalkylsubstancespfasinmembraneconcentrates